Vimarsana
Biggest News Aggregation in the World

Rapid Turnaround News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rapid Turnaround. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rapid Turnaround Today - Breaking & Trending Today

Global Polymerase Chain Reaction for qPCR, dPCR, Singleplex & Multiplex Markets, 2023-2024 and 2027: Lowering Costs, Improving Outcomes and Battling Against Anti Microbial Resistance - Vimarsana News

Global Polymerase Chain Reaction for qPCR, dPCR, Singleplex & Multiplex Markets, 2023-2024 and 2027: Lowering Costs, Improving Outcomes and Battling Against Anti Microbial Resistance

/PRNewswire/ -- The "PCR Markets. Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets and by Application, Product and Place. With Executive and Consultant...

Gravity Diagnostics Expands Testing Services to Include - Vimarsana News

Gravity Diagnostics Expands Testing Services to Include

Covington, KY, Sept. 20, 2023 (GLOBE NEWSWIRE) -- **FOR IMMEDIATE RELEASE** [[Covington, KY] – [9/20/23] – Gravity Diagnostics, a leading clinical...

Global PCR Market Forecasting and Analysis Report 2023-2027: Disruption Looms as Diagnostics Moves Out of the Hospital - Vimarsana News

Global PCR Market Forecasting and Analysis Report 2023-2027: Disruption Looms as Diagnostics Moves Out of the Hospital

/PRNewswire/ -- The "PCR Markets. Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets and by Application, Product and Place. With Executive and Consultant...

Hologic, Inc.: Hologic to Acquire Mobidiag, Innovator in Near-Patient, Acute Care Diagnostic Testing, for Approximately $795 Million - Vimarsana News

Hologic, Inc.: Hologic to Acquire Mobidiag, Innovator in Near-Patient, Acute Care Diagnostic Testing, for Approximately $795 Million

(0) -- Transaction Will Accelerate Global Growth of Mobidiag's Differentiated Molecular Platform, which Offers Ease of Use, Multiplex Capability and Rapid Turnaround Time -- Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, announced today that it has signed a definitive agreement to acquire Mobidiag Oy, a privately held, commercial-stage Finnish-French developer of innovative molecular diagnostic tests and instrumentation, for an enterprise value of approximately $795 million. This includes a cash payment of approximately $714 million (€600 million) for Mobidiag's equity, an...